Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes

Journal of Neuroimmunology

Volumn 152, Issue 1-2, 2004, Pages 98-111

  Boffey, Judith ^a   Nicholl, Dawn ^a   Wagner, Eric R ^a   Townson, Kate ^a   Goodyear, Carl ^a,b,d   Furukawa, Keiko ^c   Furukawa, Koichi ^c   Conner, Joe ^a,b   Willison, Hugh J ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoantibodies; Gangliosides; Innate immunity; Lipopolysaccharide; Neuropathy; V gene usage

Indexed keywords

AUTOANTIBODY; CD5 ANTIGEN; CROSS REACTING ANTIBODY; DISIALOSYL ANTIBODY; EPITOPE; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BINDING AFFINITY; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; GENE REARRANGEMENT; GUILLAIN BARRE SYNDROME; HYBRIDOMA; MOUSE; NEUROIMMUNOLOGY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; AUTOANTIBODIES; B-LYMPHOCYTES; BASE SEQUENCE; CAMPYLOBACTER JEJUNI; EPITOPES, B-LYMPHOCYTE; GANGLIOSIDES; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; LIPOPOLYSACCHARIDES; MICE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

EID: 3042604831     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.04.002     Document Type: Article

References (58)

1. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402
2. Antone S.M., Adderson E.E., Mertens N.M., Cunningham M.W. Molecular analysis of V gene sequences encoding cytotoxic anti-streptococcal/anti-myosin monoclonal antibody 36.2.2 that recognizes the heart cell surface protein laminin. J. Immunol. 159:1997;5422-5430
3. Appel R.D., Bairoch A., Hochstrasser D.F. A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server. Trends Biochem. Sci. 19:1994;258-260
4. Aspinall G.O., McDonald A.G., Pang H., Kurjanczyk L.A., Penner J.L. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry. 33:1994;241-249
5. Boucher G., Broly H., Lemieux R. Restricted use of cationic germline V(H) gene segments in human Rh(D) red cell antibodies. Blood. 89:1997;3277-3286
6. Bowes T., Wagner E.R., Boffey J., Nicholl D., Cochrane L., Benboubetra M., Conner J., Furukawa K., Furukawa K., Willison H.J. Tolerance to self-gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barre syndrome. Infect. Immun. 70:2002;5008-5018
7. Bullens R.W., O'Hanlon G.M., Wagner E., Molenaar P.C., Furukawa K., Furukawa K., Plomp J.J., Willison H.J. Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J. Neurosci. 22:2002;6876-6884
8. Cerato E., Birkle S., Portoukalian J., Mezazigh A., Chatal J.F., Aubry J. Variable region gene segments of nine monoclonal antibodies specific to disialogangliosides (GD2, GD3) and their O-acetylated derivatives. Hybridoma. 16:1997;307-316
9. Chapman P.B., Yuasa H., Houghton A.N. Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside. J. Immunol. 145:1990;891-898
10. Chen Z.C., Radic M.Z., Galili U. Genes coding evolutionary novel anti-carbohydrate antibodies: studies on anti-Gal production in alpha 1, 3galactosyltransferase knock out mice. Mol. Immunol. 37:2000;455-466
11. Clackson T., Hoogenboom H.R., Griffiths A.D., Winter G. Making antibody fragments using phage display libraries. Nature. 352:1991;624-628
12. Dippold W.G., Lloyd K.O., Li L.T., Ikeda H., Oettgen H.F., Old L.J. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A. 77:1980;6114-6118
13. Fidanza V., Mayer R., Zaghouani H., DiLiberti M.A., Bona C.A. Autoantibodies, LY-1, and immunoglobulin V gene expression in hybridomas obtained from young and from old New Zealand black mice. Arthritis Rheum. 33:1990;711-723
14. Goodyear C.S., O'Hanlon G.M., Plomp J.J., Wagner E.R., Morrison I., Veitch J., Cochrane L., Bullens R.W., Molenaar P.C., Conner J., Willison H.J. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J. Clin. Invest. 104:1999;697-708
15. Helling F., Shang A., Calves M., Zhang S., Ren S., Yu R.K., Oettgen H.F., Livingston P.O. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines. Cancer Res. 54:1994;197-203
16. Ho T.W., Mckhann G.M., Griffin J.W. Human autoimmune neuropathies. Annu. Rev. Neurosci. 21:1998;187-226
17. Ho T.W., Willison H.J., Nachamkin I., Li C.Y., Veitch J., Ung H., Wang G.R., Liu R.C., Cornblath D.R., Asbury A.K., Griffin J.W., Mckhann G.M. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann. Neurol. 45:1999;168-173
18. Hughes R.A.C., Hadden R.D.M., Gregson N.A., Smith K.J. Pathogenesis of Guillain-Barré syndrome. J. Neuroimmunol. 100:1999;74-97
19. Jeong H.D., Teale J.M. Contribution of the CD5+ B cell to D-proximal VH family expression early in ontogeny. J. Immunol. 145:1990;2725-2729
20. Kabat E.A., Wu T.T., Perry H.M., Gotterman K.S., Foeller C. Sequences of Proteins of Immunological Interest. 5th ed. 1991;US Department of Health and Human Services, Bethesda, MD
21. Kaminski M.J., MacKenzie C.R., Mooibroek M.J., Dahms T.E., Hirama T., Houghton A.N., Chapman P.B., Evans S.V. The role of homophilic binding in anti-tumor antibody R24 recognition of molecular surfaces. Demonstration of an intermolecular beta-sheet interaction between vh domains. J. Biol. Chem. 274:1999;5597-5604
22. Kang C.Y., Brunck T.K., Kieber-Emmons T., Blalock J.E., Kohler H. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. Science. 240:1988;1034-1036
23. Kasturi K.N., Daian C., Saitoh Y., Muryoi T., Bona C.A. Tight-skin mouse autoantibody repertoire: analysis of VH and VK gene usage. Mol. Immunol. 30:1993;969-978
24. Kaushik A., Mayer R., Fidanza V., Zaghouani H., Lim A., Bona C., Dighiero G. Ly1 and V-gene expression among hybridomas secreting natural autoantibody. J. Autoimmun. 3:1990;687-700
25. Kearney J.F., Won W.J., Benedict C., Moratz C., Zimmer P., Oliver A., Martin F., Shu F. B cell development in mice. Int. Rev. Immunol. 15:1997;207-241
26. Kimura H., Buescher E.S., Ball E.D., Marcus D.M. Restricted usage of VH and V kappa genes by murine monoclonal antibodies against 3-fucosyllactosamine. Eur. J. Immunol. 19:1989;1741-1746
27. Lefranc M.P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 31:2003;307-310
28. Lunn M.P., Johnson L.A., Fromholt S.E., Itonori S., Huang J., Vyas A.A., Hildreth J.E., Griffin J.W., Schnaar R.L., Sheikh K.A. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J. Neurochem. 75:2000;404-412
29. Malkiel S., Liao L., Cunningham M.W., Diamond B. T-Cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin. Infect. Immun. 68:2000;5803-5808
30. Martin F., Kearney J.F. B1 cells: similarities and differences with other B cell subsets. Curr. Opin. Immunol. 13:2001;195-201
31. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 14:2001;617-629
32. Mayer L.D., Bally M.B., Hope M.J., Cullis P.R. Techniques for encapsulating bioactive agents into liposomes. Chem. Phys. Lipids. 40:1986;333-345
33. Mertens N.M., Galvin J.E., Adderson E.E., Cunningham M.W. Molecular analysis of cross-reactive anti-myosin/anti-streptococcal mouse monoclonal antibodies. Mol. Immunol. 37:2000;901-913
34. Muldoon J., Shashkov A.S., Moran A.P., Ferris J.A., Senchenkova S.N., Savage A.V. Structures of two polysaccharides of Campylobacter jejuni 81116. Carbohydr. Res. 337:2002;2223-2229
35. O'Hanlon G.M., Bullens R.W., Plomp J.J., Willison H.J. Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective. Neurochem. Res. 27:2002;697-709
36. O'Hanlon G.M., Plomp J.J., Chakrabarti M., Morrison I., Wagner E.R., Goodyear C.S., Yin X., Trapp B.D., Conner J., Molenaar P.C., Stewart S., Rowan E.G., Willison H.J. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain. 124:2001;893-906
37. Paterson G., Wilson G., Kennedy P.G., Willison H.J. Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. J. Immunol. 155:1995;3049-3059
38. Penner J.L., Aspinall G.O. Diversity of lipopolysaccharide structures in Campylobacter jejuni. J. Infect. Dis. 176(Suppl. 2):1997;S135-S138
39. Pukel C.S., Lloyd K.O., Travassos L.R., Dippold W.G., Oettgen H.F., Old L.J. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J. Exp. Med. 155:1982;1133-1147
40. Ruf J., Ferrand M., Durand-Gorde J.M., Carayon P. Autoantibodies and monoclonal antibodies directed to an immunodominant antigenic region of thyroglobulin interact with thyroperoxidase through an interspecies idiotype. Autoimmunity. 19:1994;55-62
41. Sadigh S., Scott B.B., Mageed R.A., Malcolm A., Andrew E.M., Maini R.N. Identification of hybridomas derived from mouse CD5+ B lymphocytes by fluorescent staining for cytoplasmic CD5 expression. Immunology. 81:1994;558-563
42. Salloway S., Mermel L.A., Seamans M., Aspinall G.O., Nam Shin J.E., Kurjanczyk L.A., Penner J.L. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3. Infect. Immun. 64:1996;2945-2949
43. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U. S. A. 74:1977;5463-5467
44. Schillbach J.F., Near R.I., Bruccoleri R.E., Haber E., Jeffrey P.D., Novotny J., Sheriff S., Margolies M.N. Modulation of antibody affinity by a non-contact residue. Protein Sci. 2:1993;206-214
45. Shin J.E., Ackloo S., Mainkar A.S., Monteiro M.A., Pang H., Penner J.L., Aspinall G.O. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10. Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome and from the serotype reference strain. Carbohydr. Res. 305:1997;223-232
46. Snapper C.M., Mond J.J. A model for induction of T-cell-Independent Humoral immunity in response to polysaccharide antigens. J. Immunol. 157:1996;2229-2233
47. Snyder J.G., Weng N., Yu-Lee L.Y., Marcus D.M. Heavy and light chain sequences of four monoclonal antibodies that bind galactosylgloboside (GalGb4). Eur. J. Immunol. 20:1990;2673-2677
48. Susuki K., Yuki N., Hirata K. Features of sensory ataxic neuropathy associated with anti-GD1b IgM antibody. J. Neuroimmunol. 112:2001;181-187
49. Susuki K., Yuki N., Hirata K. Fine specificity of anti-GQ1b IgG and clinical features. J. Neurol. Sci. 185:2001;5-9
50. Takamiya K., Yamamoto A., Furukawa K., Yamashiro S., Shin M., Okada M., Fukumoto S., Haraguchi M., Takeda N., Fujimura K., Sakae M., Kishikawa M., Shiku H., Furukawa K., Aizawa S. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. U. S. A. 93:1996;10662-10667
51. Vos Q., Lees A., Qi Wu Z., Snapper C.M., Mond J.J. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176:2000;154-170
52. Weng N.P., Ritter E., Yucel E., Zhang D., Ritter G., Marcus D.M. Specificity and structure of murine monoclonal antibodies against GM1 ganglioside. J. Neuroimmunol. 55:1994;61-68
53. Willison H.J., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 125:2002;2591-2625
54. Willison H.J., O'Hanlon G.M., Paterson G., Veitch J., Wilson G., Roberts M., Tang T., Vincent A. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J. Clin. Invest. 97:1996;1155-1164
55. Winer J.B. Guillain-Barré syndrome. Mol. Pathol. 54:2001;381-385
56. Won W.J., Kearney J.F. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168:2002;5605-5611
57. Yan X., Evans S.V., Kaminki M.J., Gillies S.D., Reisfeld R.A., Houghton A.N., Chapman P.B. Characterization of an Ig, V.H., idiotope that results in specific homophilic binding and increased avidity for antigen. J. Immunol. 157:1996;1582-1588
58. Zandvoort A., Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin. Exp. Immunol. 130:2002;4-11